Status:
ACTIVE_NOT_RECRUITING
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Eligibility:
All Genders
18-80 years
Brief Summary
This is a retrospective, multicenter study focused on patients with a known diagnosis of PMLBCL which experienced a CNS relapse during the course of their disease to obtain information about the clini...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Histologically confirmed diagnosis of Primary Mediastinal Large B Cell Lymphoma (PMLBCL) according WHO Classification
- Had a recurrence/progression with Central Nervous System (CNS) involvement
- Availability of details on clinical presentation, treatment details and outcome
- Availability of details on pathological data for central review
- Age ≥18 years
- Exclusion Criteria
- Patients with CNS lymphoma other than PMLBCL subtype
Exclusion
Key Trial Info
Start Date :
June 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 10 2027
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06024694
Start Date
June 30 2022
End Date
June 10 2027
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale San Raffaele
Milan, Italy, Italy, 20132